Autoantibodies and COVID-19: Rediscovering Nonspecific Polyclonal B-Cell Activation?
- PMID: 35313338
- PMCID: PMC8992343
- DOI: 10.1093/infdis/jiac105
Autoantibodies and COVID-19: Rediscovering Nonspecific Polyclonal B-Cell Activation?
Comment in
-
Reply to Cimolai: Post-COVID syndrome and autoimmunity.J Infect Dis. 2022 Sep 4;226(4):753-754. doi: 10.1093/infdis/jiac106. J Infect Dis. 2022. PMID: 35313345 No abstract available.
Comment on
-
Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome.J Infect Dis. 2022 Jun 15;225(12):2155-2162. doi: 10.1093/infdis/jiac017. J Infect Dis. 2022. PMID: 35079804 Free PMC article.
References
-
- Granholm NA, Cavallo T.. Autoimmunity, polyclonal B-cell activation and infection. Lupus 1992; 1:63–74. - PubMed
-
- Hunziker L, Recher M, Macpherson AJ, et al. Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections. Nat Immunol 2003; 4:343–9. - PubMed
-
- Montes CL, Acosta-Rodriguez EV, Merino MC, Bermejo DA, Gruppi A.. Polyclonal B cell activation in infections: infectious agents’ devilry or defense mechanism of the host? J Leukoc Biol 2007; 82:1027–32. - PubMed
-
- Cimolai N, Cheong ACH.. Anti-smooth muscle antibody in clinical human and experimental animal Mycoplasma pneumoniae infection. J Appl Microbiol 1997; 82:625–30. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
